Navigation Links
Almost as sensitive as a dog's nose
Date:8/28/2013

ute of Energy Technology. With today's SERS sensors, however, the signal strength is adequate only in isolated cases and yields results with low reproducibility. Altun, Bond and Park therefore set themselves the goal of developing a sensor that massively amplifies the signals of the Raman-scattered light.

The substrate of choice turned out to be vertically arranged, caespitose, densely packed carbon nanotubes (CNT) that guarantee this high density of 'hot spots'. The group developed techniques to grow dense forests of CNTs in a uniform and controlled manner. The availability of this expertise was one of the principal motivations for using nanotubes as the basis for highly sensitive SERS sensors, says Park.

A spaghetti-like surface

The tips of the CNTs are sharply curved, and the researchers coated these tips with gold and hafnium dioxide, a dielectric insulating material. The point of contact between the surface of the sensor and the sample thus resembles a plate of spaghetti topped with sauce. However, between the strands of spaghetti, there are numerous randomly arranged holes that let through scattered light, and the many points of contact -- the 'hot spots' -- amplify the signals.

"One method of making highly sensitive SERS sensors is to take advantage of the contact points of metal nanowires," explains Park. The nano-spaghetti structure with metal-coated CNT tips is perfect for maximising the density of these contact points.

Indeed, Bond explains, the wide distribution of metallic nano-crevices in the nanometre range, well recognised to be responsible for extreme electromagnetic enhancement (or hot spots) and highly pursued by many research groups, has been easily and readily achieved by the team, resulting in the intense and reproducible enhancements.

The sensor differs from other comparable ultra-sensitive SERS sensors not only in terms of its structure, but also because of its relatively inexpen
'/>"/>

Contact: Hyung Gyu Park
parkh@ethz.ch
41-446-329-460
ETH Zurich
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. New report confirms almost half of Africas lions facing extinction
2. Mutant champions save imperiled species from almost-certain extinction
3. Researchers design sensitive new microphone modeled on fly ear
4. More accurate, sensitive DNA test allows early identification of fungus causing WNS
5. Why a hereditary anemia is caused by genetic mutation in mechanically sensitive ion channel
6. New study reveals how sensitive US East Coast regions may be to ocean acidification
7. Sodium transporter appears likely target for treating salt-sensitive hypertension
8. The worlds most sensitive plasmon resonance sensor inspired by ancient Roman cup
9. Touch-sensitive plastic skin heals itself
10. Tactile croc jaws more sensitive than human fingertips
11. Ultrasensitive photon hunter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/7/2015)... , May 7, 2015 ... fingerprint sensors, FPC1022 and FPC1035, FPC,s smallest touch ... FPC1035 are mainly considered for integration on the ... gives smartphone OEMs increased possibilities to integrate touch ... decreased size also improves possibilities for module manufacturers ...
(Date:4/27/2015)... 2015  For more than four decades, AUVSI,s ... the premier worldwide event for the unmanned land, sea, ... event for any local, national, or trade news organization ... markets and current applications of unmanned technologies. The conference ... $48 billion industry, and how it will soon impact ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... 18, 2009 Pharmaceuticals and personal care products (PPCPs) ... reach surface waters or groundwater when these materials ... the high flow conditions created by land application ... of solutes in soil macropores may be too ...
... radiation therapy treatment damages a patient,s healthy tissue as ... destroy, making the treatment especially invasive and often causing ... will enable a far more precise and accurate treatment ... the radiation beam. Real-time image-guided radiotherapy, combining radiation ...
... available in French . , Montreal, May ... known to humans, and its abuse has become widespread since ... we know rather little about its effects on the human ... latest article by Dr. Marco Leyton, of the Montreal Neurological ...
Cached Biology News:Simulating pharmaceutical and personal care product transport 2Cocaine: Perceived as a reward by the brain? 2
(Date:6/2/2015)... Cord Blood Corporation (NYSE: CO ) ("CCBC," the "Company," ... provider of cord blood collection, laboratory testing, hematopoietic stem cell ... Special Committee of the Company,s board of directors (the "Special ... ) Limited as its independent financial advisor, Cleary ... United States legal counsel and Maples & Calder ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 German-based Moenninghoff ... United States distributor for the Moenninghoff product line ... “I am pleased to announce that the R.M. Hoffman ... For our firm, founded in 1916, this is a ... Hoffman is the kind of professional distributor we need ...
(Date:6/1/2015)... South Korea , June 1, 2015 ... Inc. (GCBT) kicked off construction today on its biopharmaceutical ... Saint-Laurent Campus. The CA$315 million project represents one of ... Canada in the biopharmaceutical industry, giving place ... and albumin manufacturing plant in Canada ...
(Date:6/1/2015)... HANOVER, N.J. , June 1, 2015 /PRNewswire/ ... II clinical study of CTL019, an investigational chimeric ... its potential in the treatment of specific types ... study conducted by the University of Pennsylvania,s Perelman ... or refractory (r/r) diffuse large B-cell lymphoma (DLBCL) ...
Breaking Biology Technology:China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6
... , BIRMINGHAM, Ala. , Jan. 19 ... when it comes to cholesterol. According to a new study, a ... — can be labeled "bad cholesterol." The landmark study Genetic ... published in the New England Journal Of Medicine provides ...
... , , NEW HAVEN, Conn. , ... today that it has appointed Dr. Richard J. Carroll ... Research. , Dr. Carroll brings to HistoRx over 20 years ... diagnostic, pharmaceutical and medical device industries. Before joining HistoRx in ...
... CITY, China , Jan. 19 /PRNewswire-Asia-FirstCall/ -- ... fully,integrated and highly innovative biopharmaceutical company engaged in the,research and ... today announced financial results for the second quarter ended, November ... 2010 Highlights, -- Total revenue increased by ...
Cached Biology Technology:New Study: Lp(a) Joins LDL as Heart Disease Risk Factor 2New Study: Lp(a) Joins LDL as Heart Disease Risk Factor 3HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research 2HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research 3Sinobiopharma Announces Second Quarter 2010 Financial Results 2Sinobiopharma Announces Second Quarter 2010 Financial Results 3Sinobiopharma Announces Second Quarter 2010 Financial Results 4
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
...
Antibody Diluent for IHC 125 ml...
Biology Products: